Czer L S, Shoemaker W C
Surg Gynecol Obstet. 1978 Sep;147(3):363-8.
Failling hematocrit values are traditionally used to observe the course of active bleeding, since hematocrit values usually reflect acute blood losses. However, evidence from the literature suggests that, after volume replacement, some degree of normovolemic hemodilution may be desirable and that return to normal hematocrit values is not necessarily the appropriate goal of transfusion therapy. The optimal hematocrit value was defined empirically by three methods in a series of 94 critically ill postoperative patients. First, the mortality rates of postoperative patients were lowest with hematocrit values between 27 and 33 per cent. Second, mortality rates were examined when both hematocrit values and the important cardiorespiratory variables were reduced; significantly increased mortalties occurred when hematocrit values were less than an average of 32 per cent. Finally, oxygen availability and oxygen consumption increased significantly after whole blood and packed red cell transfusions were given when hematocrit values were less than 32 per cent but not above 33 per cent. When accurate blood volume measurements are not available, hematocrit values of 32 per cent are optimal; when volume therapy is indicated, blood may be given with hematocrit values less than 32 per cent, crystalloids or colloids are preferred with hematocrit values greater than 32 per cent.
传统上,血细胞比容值下降用于观察活动性出血的进程,因为血细胞比容值通常反映急性失血情况。然而,文献证据表明,在进行容量补充后,一定程度的正常血容量性血液稀释可能是可取的,而且恢复到正常血细胞比容值不一定是输血治疗的合适目标。在94例术后重症患者中,通过三种方法经验性地确定了最佳血细胞比容值。首先,血细胞比容值在27%至33%之间时,术后患者的死亡率最低。其次,当血细胞比容值和重要的心肺变量都降低时,检查死亡率;当血细胞比容值平均低于32%时,死亡率显著增加。最后,当血细胞比容值低于32%但不高于33%时,输注全血和浓缩红细胞后,氧供和氧耗显著增加。当无法准确测量血容量时,32%的血细胞比容值是最佳的;当需要进行容量治疗时,血细胞比容值低于32%时可输血,血细胞比容值高于32%时则首选晶体液或胶体液。